ErbB Receptor-Driven Prolactinomas Respond to Targeted Lapatinib Treatment in Female Transgenic Mice
Xiaohai Liu, Шломо Мелмед(Cedars-Sinai Medical Center)
Cited by 37
Related Papers
EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas
|Journal of Clinical Investigation|2011|256
PPAR-γ receptor ligands: novel therapy for pituitary adenomas
|Journal of Clinical Investigation|2003|164
Clusterin and FOXL2 Act Concordantly to Regulate Pituitary Gonadotroph Adenoma Growth
|Molecular Endocrinology|2012|30